Korting Hc

647 total citations
40 papers, 461 citations indexed

About

Korting Hc is a scholar working on Epidemiology, Dermatology and Microbiology. According to data from OpenAlex, Korting Hc has authored 40 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Dermatology and 9 papers in Microbiology. Recurrent topics in Korting Hc's work include Reproductive tract infections research (8 papers), Nail Diseases and Treatments (7 papers) and Bacterial Infections and Vaccines (4 papers). Korting Hc is often cited by papers focused on Reproductive tract infections research (8 papers), Nail Diseases and Treatments (7 papers) and Bacterial Infections and Vaccines (4 papers). Korting Hc collaborates with scholars based in Germany, Switzerland and United Kingdom. Korting Hc's co-authors include Claudia Schöllmann, Monika Schäfer‐Korting, E. Mutschler, Ortonne Jp, M.-H. Schmid-Wendtner, G. Klebe, M Dorn, Gertraud Krähn, Wendy Stock and Petra Gottlöber and has published in prestigious journals such as Journal of the European Academy of Dermatology and Venereology, Acta Dermato Venereologica and Archives of Dermatological Research.

In The Last Decade

Korting Hc

39 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Korting Hc Germany 9 159 123 106 56 55 40 461
Jörg Tittelbach Germany 10 102 0.6× 69 0.6× 110 1.0× 43 0.8× 32 0.6× 54 362
İlgen Ertam Türkiye 13 236 1.5× 37 0.3× 50 0.5× 21 0.4× 90 1.6× 45 535
Barbara Behm Germany 6 143 0.9× 231 1.9× 33 0.3× 56 1.0× 31 0.6× 8 533
Tanja Illing Germany 7 157 1.0× 54 0.4× 64 0.6× 26 0.5× 30 0.5× 8 352
Anne Halbert Australia 13 208 1.3× 76 0.6× 57 0.5× 122 2.2× 28 0.5× 24 613
Sanjeev Gupta India 12 210 1.3× 15 0.1× 113 1.1× 137 2.4× 122 2.2× 56 668
Alexander Karl Germany 6 121 0.8× 46 0.4× 42 0.4× 35 0.6× 30 0.5× 15 801
Kornélia Kis Hungary 10 324 2.0× 22 0.2× 95 0.9× 47 0.8× 98 1.8× 11 703
Ziwei Jiang China 5 135 0.8× 107 0.9× 41 0.4× 50 0.9× 13 0.2× 13 427
William D Tutrone United States 13 179 1.1× 22 0.2× 270 2.5× 25 0.4× 190 3.5× 24 541

Countries citing papers authored by Korting Hc

Since Specialization
Citations

This map shows the geographic impact of Korting Hc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Korting Hc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Korting Hc more than expected).

Fields of papers citing papers by Korting Hc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Korting Hc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Korting Hc. The network helps show where Korting Hc may publish in the future.

Co-authorship network of co-authors of Korting Hc

This figure shows the co-authorship network connecting the top 25 collaborators of Korting Hc. A scholar is included among the top collaborators of Korting Hc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Korting Hc. Korting Hc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hc, Korting, et al.. (2010). Efficacy and tolerability of pale sulfonated shale oil cream 4% in the treatment of mild to moderate atopic eczema in children: a multicentre, randomized vehicle‐controlled trial. Journal of the European Academy of Dermatology and Venereology. 24(10). 1176–1182. 37 indexed citations
2.
Hc, Korting, et al.. (2010). Management of minor acute cutaneous wounds: importance of wound healing in a moist environment. Journal of the European Academy of Dermatology and Venereology. 25(2). 130–137. 156 indexed citations
3.
Hc, Korting & Claudia Schöllmann. (2009). Current topical and systemic approaches to treatment of rosacea. Journal of the European Academy of Dermatology and Venereology. 23(8). 876–882. 73 indexed citations
4.
Schmid-Wendtner, M.-H. & Korting Hc. (2007). Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell‐mediated immunity. Journal of the European Academy of Dermatology and Venereology. 21(8). 1013–1018. 11 indexed citations
5.
Jp, Ortonne, et al.. (2006). Efficacy and safety of a new single‐dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double‐blind, placebo‐controlled study. Journal of the European Academy of Dermatology and Venereology. 20(10). 1307–1313. 31 indexed citations
6.
Hc, Korting, et al.. (2004). Vergleichende Bewertung der Wirkung und klinischen Wirksamkeit von terbinafinhaltigen und bifonazolhaltigen Topika bei der Behandlung der Fussmykose [Comparative evaluation of the activity and clinical effectiveness of terbinafine and bifonazole preparations in the treatment of pedal mycosis]. 1 indexed citations
7.
Hc, Korting, et al.. (1999). Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age.. PubMed. 54(5). 319–29. 14 indexed citations
8.
Hc, Korting, et al.. (1992). [The effect of cosmetics and dermatologic agents on skin lipids].. PubMed. 43(7). 403–8. 2 indexed citations
9.
Hc, Korting, et al.. (1989). [Multi-step increase in resistance of Neisseria gonorrhoeae isolates after repeated in-vitro subinhibitory concentrations of second-generation quinolones].. Infection. 2 indexed citations
10.
Hc, Korting, et al.. (1989). Influence of various concentrations of cefotiam and ceftizoxime on the phagocytosis of gonococci by polymorphonuclear granulocytes.. PubMed. 39(4). 428–31. 1 indexed citations
11.
Hc, Korting, et al.. (1988). [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].. PubMed. 63(1). 29–32. 1 indexed citations
12.
Ollert, Markus, et al.. (1988). [Pathomechanisms in Candida albicans infections].. PubMed. 39(8). 498–503. 1 indexed citations
14.
Hc, Korting, Monika Schäfer‐Korting, Rainer Haag, & E. Mutschler. (1984). Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea.. PubMed. 22(4). 218–20. 5 indexed citations
15.
Schäfer‐Korting, Monika, Korting Hc, M Dorn, & E. Mutschler. (1984). Ketoconazole concentrations in human skin blister fluid and plasma.. PubMed. 22(7). 371–4. 21 indexed citations
16.
Hc, Korting. (1984). [Cephalosporin allergy and cephalosporin-penicillin cross allergies with special reference to venereologic therapy of severe anaphylactic reactions].. PubMed. 35(5). 225–9. 1 indexed citations
17.
Neubert, U., Korting Hc, & G. Ruckdeschel. (1982). Susceptibility of neisseria gonorrhoeae to cefotaxime: in vitro studies and treatment results. Archives of Dermatological Research. 274(3-4). 321–326. 4 indexed citations
18.
Hc, Korting, et al.. (1981). [Multiple glomus tumors].. PubMed. 32(7). 354–8. 1 indexed citations
19.
Hc, Korting, et al.. (1981). [Amiodarone pigmentation. A rare, but typical drug side-effect].. PubMed. 32(6). 301–5. 7 indexed citations
20.
Hc, Korting, et al.. (1979). KNOCHENMARKSDEPRESSION MIT PERIPHERER PANZYTOPENIE UNTER DER GABE EINER AMPICILLIN/OXACILLIN-KOMBINATION. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026